Efficacy and safety of finerenone in patients with chronic kidney disease: an individual participant data pooled analysis (INFINITY)
NefrologiaSobre o estudo
- Desenho
- Metanálise
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- Lancet (London, England)
- Publicado em
- 5 jun 2026
- Citações
- 16
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Efficacy and safety of finerenone in patients with chronic kidney disease: an individual participant data pooled analysis (INFINITY)
Brendon L Neuen, Hiddo J L Heerspink, Vlado Perkovic, David Z I Cherney, Carolyn S P Lam, Katherine R Tuttle, Christoph Wanner, Pantelis Sarafidis, Stefan D Anker, Gerasimos Filippatos et al.
Descritores MeSH
- Mineralocorticoid Receptor Antagonists
- Naphthyridines
- Renal Insufficiency, Chronic
- Female
- Glomerular Filtration Rate
- Aged
- Male
- Middle Aged
- Randomized Controlled Trials as Topic
- Treatment Outcome
Veja também
Estudos relacionados
- Effects of finerenone on arterial stiffness and cardiorenal biomarkers in patients with type 2 diabetes and chronic kidney disease: a randomised placebo-controlled mechanistic trial (FIVE-STAR)
- Efficacy and safety of finerenone in Asian patients with type 2 diabetes and chronic kidney disease: A FIDELITY analysis by baseline kidney function
- Finerenone Across Cardiovascular-Kidney-Metabolic Syndrome Stages: Post Hoc Analysis of the FIDELITY Randomized Clinical Trials
- Finerenone in Persons with Chronic Kidney Disease without Diabetes